Author

Zack Panos

Institution: Children's Investment Fund Foundation

Observed institution: Children's Investment Fund Foundation

ORCID: 0000-0001-9312-7083

Observed ORCID: 0000-0001-9312-7083

OpenAlex ID: A5118756026

Potential impact and cost-effectiveness of long-acting injectable lenacapavir plus cabotegravir as HIV treatment in Africa

2025 · Andrew Phillips, Jennifer Smith, et al. · Nature Communications · 11

Accelerating Generic Long‐Acting Antiretrovirals for Global HIV Treatment: Workshop Findings and a Roadmap to Access

2026 · Usman Arshad, Lobna Gaayeb, et al. · Clinical Pharmacology & Therapeutics · 4

Author Correction: Potential impact and cost-effectiveness of long-acting injectable lenacapavir plus cabotegravir as HIV treatment in Africa

2026 · Andrew Phillips, Jennifer Smith, et al. · Nature Communications

Works count: 3

Citation count: 15

H-index: 2

I10-index: 1